Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine and Fluoxetine for TRD in Chinese Participants
NCT01687478Phase 3Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2012
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in treatment-resistant depression (TRD), sponsored by Eli Lilly and Company. Started Sep 2012; status: terminated.
02
Drugs
olanzapine
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT01687478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01687478.